ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch
AttivaIDI / IVA
CHE-209.784.395 MWST
Numero del registro di commercio
CH-440-1038220-9
Sede
Kreuzlingen
Scopo
Entwicklung innovativer medizinischer Diagnose- und Behandlungskonzepte für Tumorerkrankungen.
Management
AI-generated contentUnisciti al Nostro Programma Beta
Stiamo sviluppando attivamente la piattaforma. Iscriviti per l'accesso beta e ottieni accesso esclusivo in anteprima alle nuove funzionalità.
Pubblicazioni
22/05/2024
25/03/2022
Frequently Asked Questions
What is the legal status of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch?
ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch is Attiva in the Swiss Commercial Register.
What is the UID (VAT) number of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch?
The UID (VAT) number of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch is CHE-209.784.395.
Where is ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch located?
ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch is located in Kreuzlingen with its registered address at Eichhornweg 1, 8280 Kreuzlingen.
What is the legal form of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch?
ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch is registered as a Ditta individuale (IPI) in Switzerland.
What is the purpose of ATCG - Advanced Treatment Concepts against Glioblastoma Firmeninhaber: Marc-Eric Halatsch?
Entwicklung innovativer medizinischer Diagnose- und Behandlungskonzepte für Tumorerkrankungen.